When to Use Single-Dose IM Ceftriaxone (Rocephin)
A single intramuscular dose of ceftriaxone 250 mg is the first-line treatment for uncomplicated gonorrhea of the cervix, urethra, rectum, and pharynx, and must be combined with azithromycin 1 g orally to prevent resistance development. 1
Primary Indication: Uncomplicated Gonorrhea
The CDC guidelines establish ceftriaxone 250 mg IM as the cornerstone treatment for gonococcal infections at all anatomic sites. This recommendation reflects ceftriaxone's sustained bactericidal blood levels and proven efficacy (98.9% cure rate for urogenital and anorectal infections) 2. Critically, ceftriaxone should never be used alone—combination therapy with azithromycin 1 g orally (preferred) or doxycycline 100 mg twice daily for 7 days is mandatory to delay resistance emergence 1.
Specific Anatomic Sites:
- Urogenital infections (cervix, urethra): 250 mg IM × 1 dose
- Anorectal infections: 250 mg IM × 1 dose
- Pharyngeal infections: 250 mg IM × 1 dose (pharynx requires ceftriaxone specifically, as alternatives like spectinomycin are unreliable) 3
Other Single-Dose Indications
Gonococcal Conjunctivitis
Use ceftriaxone 1 g IM as a single dose plus saline lavage of the infected eye 3, 4. This higher dose (1 g vs. 250 mg) is necessary for ocular infections, with 12/12 patients responding favorably in published studies 3.
Acute Otitis Media in Children
The FDA label and research support a single IM dose of 50 mg/kg (maximum 1 g) for acute bacterial otitis media in pediatric patients 5. Studies demonstrate equivalence to 10-day oral amoxicillin courses (91% success rate) 6, making this an excellent option for:
- Non-compliant patients or families
- Vomiting children unable to tolerate oral medications
- Areas with high penicillin-resistant Streptococcus pneumoniae prevalence 7
Important caveat: Some data suggest increased middle ear effusion persistence at 30 days with single-dose ceftriaxone compared to multi-day oral therapy 8, so reserve this for situations where compliance is genuinely problematic.
Surgical Prophylaxis
A single dose of 1 g IV administered 30 minutes to 2 hours before surgery is FDA-approved for preoperative prophylaxis 5.
Critical Contraindications and Warnings
Neonates (≤28 days)
Ceftriaxone is contraindicated in neonates requiring calcium-containing IV solutions due to fatal ceftriaxone-calcium precipitation 5. Hyperbilirubinemic neonates, especially premature infants, should never receive ceftriaxone due to bilirubin displacement and encephalopathy risk 5.
Pregnancy
Pregnant women with gonorrhea should receive the same ceftriaxone regimen as non-pregnant patients (250 mg IM), but avoid quinolones and tetracyclines—use erythromycin for presumptive chlamydial coverage 3, 4.
When Single-Dose is NOT Appropriate
Do not use single-dose ceftriaxone for:
- Disseminated gonococcal infection (DGI): Requires ceftriaxone 1 g IM/IV daily for ≥1 week 3, 4, 9
- Gonococcal meningitis: Requires 1-2 g IV every 12 hours for 10-14 days 9
- Gonococcal endocarditis: Requires 1-2 g IV every 12 hours for ≥4 weeks 9
- Bacterial meningitis in children: Requires 100 mg/kg/day (max 4 g) for 7-14 days 5
- Severe pneumonia requiring mechanical ventilation: Evidence suggests 2 g daily may reduce mortality compared to 1 g daily 10
Common Pitfalls to Avoid
Never use ceftriaxone monotherapy for gonorrhea—resistance patterns demand dual therapy 1
Don't forget chlamydia coverage—if Chlamydia trachomatis cannot be ruled out, add appropriate treatment since ceftriaxone has no antichlamydial activity 5
Avoid calcium-containing diluents—use lidocaine or sterile water for IM reconstitution, never Ringer's or Hartmann's solution 5
Test-of-cure is mandatory when using alternative regimens (not ceftriaxone) or if treatment failure is suspected 1
Partner treatment is essential—evaluate and treat all sexual partners from the preceding 60 days 1